Document Detail


Risk stratification for renal transplantation after cardiac or lung transplantation: single-center experience and review of the literature.
MedLine Citation:
PMID:  17622737     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Long-term survival after heart (HTx) or lung (LuTx) transplantation increases the risk for end-stage renal disease (ESRD). After HTx ESRD was reported to enhance mortality, and kidney transplantation (KTx) was shown to improve survival. However, prognostic factors in ESRD after HTx or LuTx are largely unknown. METHODS: Single-center observational study in HTx and LuTx patients who accessed the KTx waiting list; baseline characteristics were correlated with mortality. RESULTS: KTx was performed in 15 of 65 study patients. Survival was comparable on the KTx waiting list and in reference patients from the same center without ESRD. KTx significantly improved survival (5 years' survival 84.6% with KTx vs. 56.5% on the KTx waiting list, p = 0.030). None of the baseline parameters predicted mortality in the KTx group. Only on the KTx waiting list BMI (median 24.7 vs. 20.7; p < 0.05) and left ventricular ejection fraction (LVEF, median 63 vs. 53%, p < 0.008) significantly correlated with survival. CONCLUSIONS: The risk for mortality after HTx or LuTx is not increased by ESRD, provided that patients meet access criteria for the KTx waiting list. KTx improves survival in ESRD after HTx or LuTx. BMI and LVEF may predict outcome in HTx/LuTx patients on the KTx waiting list.
Authors:
Christian Rosenberger; Julia Stein; Jan Steffen Jürgensen; Nermin Eibl; Nina Babel; Ulrike Bachmann; Dagmar Kemper; Christoph Knosalla; Roland Hetzer; Ulrich Frei; Hans Lehmkuhl; Petra Reinke
Related Documents :
19010157 - Model for end-stage liver disease can predict very early outcome after liver transplant...
18239987 - Non-isotopic tyrosine kinetics using an alanyl-tyrosine dipeptide to assess graft funct...
20187107 - Sirolimus-based immunosuppression is associated with increased survival after liver tra...
15113357 - Liver and intestine transplantation.
1403237 - Antihypertensive therapy in renal disease and transplantation.
10964027 - The molecular basis of renal tubular transport disorders.
Publication Detail:
Type:  Comparative Study; Journal Article; Review     Date:  2007-06-29
Journal Detail:
Title:  Kidney & blood pressure research     Volume:  30     ISSN:  1423-0143     ISO Abbreviation:  Kidney Blood Press. Res.     Publication Date:  2007  
Date Detail:
Created Date:  2007-07-19     Completed Date:  2007-09-07     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9610505     Medline TA:  Kidney Blood Press Res     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  260-6     Citation Subset:  IM    
Copyright Information:
Copyright 2007 S. Karger AG, Basel.
Affiliation:
Nephrology and Medical Intensive Care, Charité Universitätsmedizin, Berlin, Germany. chrosenbe@aol.com <chrosenbe@aol.com>
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Female
Heart Transplantation / adverse effects*,  mortality*,  trends
Humans
Kidney Transplantation / adverse effects*,  mortality*,  trends
Lung Transplantation / adverse effects*,  mortality*,  trends
Male
Middle Aged
Risk Factors
Survival Rate / trends
Time Factors

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The endothelial glycocalyx prefers albumin for evoking shear stress-induced, nitric oxide-mediated c...
Next Document:  PPAR-gamma activation inhibits angiotensin II synthesis, apoptosis, and proliferation of mesangial c...